ARS Pharmaceuticals, Inc. Insider Transactions
ARS Pharmaceuticals, Inc. Insider Trades History
| Insider Name | Buy/Sell | Shares Bought/Sold @ Price |
Total Transaction | Shares Held After Transaction |
Transaction Date | Filing Date | Details |
|---|---|---|---|---|---|---|---|
|
Chakma Justin
Chief Business Officer |
Sell | 27,272 @ $12.06 | $328,969 | 136,380 | 12/13/2024 | 12/13/2024 | |
|
Chakma Justin
Chief Business Officer |
Sell | 117,333 @ $12.27 | $1.44 M | 136,380 | 12/12/2024 | 12/13/2024 | |
|
Dorsey Brian
COO |
Sell | 25,000 @ $12.30 | $307,433 | 6,024 | 12/12/2024 | 12/13/2024 | |
|
Dorsey Brian
COO |
Sell | 15,000 @ $12.43 | $186,426 | 6,024 | 12/11/2024 | 12/13/2024 | |
|
Tanimoto Sarina
10 percent owner, CHIEF MEDICAL OFFICER |
Sell | 50,000 @ $13.16 | $658,155 | 1,148,499 | 12/10/2024 | 12/11/2024 | |
| Sell | 50,000 @ $13.16 | $658,155 | 1,148,499 | 12/10/2024 | 12/11/2024 | ||
|
Chakma Justin
Chief Business Officer |
Sell | 50,000 @ $13.15 | $657,625 | 136,380 | 12/10/2024 | 12/12/2024 | |
|
Chakma Justin
Chief Business Officer |
Sell | 50,000 @ $14.23 | $711,615 | 136,380 | 12/06/2024 | 12/06/2024 | |
|
Chakma Justin
Chief Business Officer |
Sell | 49,640 @ $14.13 | $701,642 | 136,380 | 12/05/2024 | 12/06/2024 | |
|
Chakma Justin
Chief Business Officer |
Sell | 45,000 @ $13.95 | $627,944 | 136,380 | 12/04/2024 | 12/06/2024 | |
|
Shawver Laura
Director |
Sell | 14,772 @ $13.75 | $203,109 | 210,346 | 12/04/2024 | 12/04/2024 | |
|
Karas Eric
Chief Commercial Officer |
Sell | 6,283 @ $14.00 | $87,962 | 5,693 | 12/04/2024 | 12/04/2024 | |
|
Chakma Justin
Chief Business Officer |
Sell | 45,000 @ $13.19 | $593,402 | 136,380 | 12/03/2024 | 12/04/2024 | |
|
Shawver Laura
Director |
Sell | 87,984 @ $13.26 | $1.17 M | 210,346 | 12/03/2024 | 12/04/2024 | |
|
Chakma Justin
Chief Business Officer |
Sell | 45,000 @ $13.67 | $615,218 | 136,380 | 12/02/2024 | 12/04/2024 | |
|
Shawver Laura
Director |
Sell | 96,343 @ $13.55 | $1.31 M | 211,247 | 12/02/2024 | 12/04/2024 | |
|
Shawver Laura
Director |
Sell | 901 @ $14.34 | $12,922 | 210,346 | 12/02/2024 | 12/04/2024 | |
|
Karas Eric
Chief Commercial Officer |
Sell | 3,717 @ $14.11 | $52,461 | 5,693 | 12/02/2024 | 12/04/2024 | |
|
Chakma Justin
Chief Business Officer |
Sell | 25,000 @ $14.39 | $359,750 | 136,380 | 11/27/2024 | 11/27/2024 | |
|
Chakma Justin
Chief Business Officer |
Sell | 42,186 @ $14.05 | $592,570 | 161,380 | 11/26/2024 | 11/27/2024 |
ARS Pharmaceuticals, Inc. FAQ's
Who is on ARS Pharmaceuticals, Inc.'s Insider
Roster?
The list of insiders at ARS Pharmaceuticals, Inc. includes Lowenthal Richard E, Tanimoto Sarina, RA CAPITAL MANAGEMENT, L.P., Karas Eric, Dorsey Brian, ORBIMED ADVISORS LLC, Thompson Peter A., Scott Kathleen D., Flynn James E, Chakma Justin, Shawver Laura.
How much insider selling is happening at
ARS Pharmaceuticals, Inc.?
Insiders have sold a total of 5.27 M ARS Pharmaceuticals, Inc. shares in the last 12 months for a total of 67.01 M sold.
Which ARS Pharmaceuticals, Inc. insiders have been
selling company stock?
The following insiders have sold ARS Pharmaceuticals, Inc. shares in the last 12 months: Lowenthal Richard E ($12.41 M), Tanimoto Sarina ($12.41 M), Karas Eric ($420,423), Dorsey Brian ($1.24 M), ORBIMED ADVISORS LLC ($12.59 M), Thompson Peter A. ($12.59 M), Scott Kathleen D. ($200,000), Flynn James E ($5.38 M), Chakma Justin ($7.09 M), Shawver Laura ($2.69 M),
How much insider buying is happening at
ARS Pharmaceuticals, Inc.?
Insiders have purchased a total of 1.40 M ARS Pharmaceuticals, Inc. shares in the last 12 months for a total of 13.29 M sold.
Which ARS Pharmaceuticals, Inc. insiders have been
buying company stock?
The following insiders have purchased ARS Pharmaceuticals, Inc. shares in the last 12 months: RA CAPITAL MANAGEMENT, L.P. ($13.29 M),